Belinda Wood is the CEO of the Generic and Biosimilar Medicines Association (GBMA). Previously the Generic Medicines Industry Association, GBMA is the Australian association representing companies that manufacture, supply and export generic and biosimilar medicines. Belinda has over 20 years’ experience in the pharmaceutical industry and was appointed CEO in December 2014 having been the organisation’s Policy Director from 2012. Belinda was pivotal in negotiations leading to the signing of a Strategic Agreement with the Australian Government in May 2015 that recognises the important role of generic medicines and biosimilars in PBS affordability. The Agreement provides GBMA members with 5-years pricing policy certainty and a direct line into Government through the Generic Medicines Working Group. Belinda holds a BMedSc in Pharmacology and currently sits on several industry committees including the Drug Utilisation Sub Committee (DUSC) and TGA Industry Working Group. – See more at: